Cencora, Inc. (ETR:ABG)

Market Cap	57.14B
Revenue (ttm)	273.87B +9.3%
Net Income	1.32B +3.0%
EPS	6.78 +5.7%
Shares Out	n/a
PE Ratio	43.14
Forward PE	19.97
Dividend	2.17 (0.73%)
Ex-Dividend Date	Nov 14, 2025

Volume	n/a
Average Volume	27
Open	298.20
Previous Close	297.65
Day's Range	298.20 - 298.20
52-Week Range	244.95 - 325.25
Beta	n/a
RSI	48.19
Earnings Date	Feb 4, 2026

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1871
• Employees: 51,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ABG

Financial Performance

In 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD